Search Results - S K Soloviev

Refine Results
  1. 1
    ACTUARIAL STUDY OF DEMOGRAPHIC FACTORS CONTRIBUTING TO THE HIGHER RETIREMENT AGE

    ACTUARIAL STUDY OF DEMOGRAPHIC FACTORS CONTRIBUTING TO THE HIGHER RETIREMENT AGE by A. K. Soloviev, B. Y. Popov

    Published 2017-10-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Resolution of the Expert Council «The role of type I interferon inhibitor in the treatment of patients with systemic lupus erythematosus»

    Resolution of the Expert Council «The role of type I interferon inhibitor in the treatment of patients with systemic lupus erythematosus» by A. M. Lila, S. K. Soloviev, T. V. Popkova

    Published 2021-08-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    CLINICAL-LABORATORY REMISSION IN A PATIENT WITH RHEUMATOID ARTHRITIS AFTER APPLICATION OF SYNCHRONIC PROGRAM INTENSIVE THERAPY (SPIT)

    CLINICAL-LABORATORY REMISSION IN A PATIENT WITH RHEUMATOID ARTHRITIS AFTER APPLICATION OF SYNCHRONIC PROGRAM INTENSIVE THERAPY (SPIT) by E A Aseyeva, S K Soloviev, A S Chiklikchi

    Published 2001-04-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Systemic lupus erythematosus: history and modernity

    Systemic lupus erythematosus: history and modernity by E. L. Nasonov, S. K. Soloviev, A. V. Arshinov

    Published 2022-09-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    EFFECACY OF PULSE-THERAPY WIHT GLUCOCORTICOSTEROIDS AND METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS

    EFFECACY OF PULSE-THERAPY WIHT GLUCOCORTICOSTEROIDS AND METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS by N YU Lashina, E A Aseveva, S K Soloviev

    Published 2000-02-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Prospects for the use of belimumab in lupus nephritis

    Prospects for the use of belimumab in lupus nephritis by N. L. Kozlovskaya, S. K. Soloviev, E. A. Aseeva

    Published 2021-08-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    T-regulatory cells in systemic lupus erythematosus and rheumatoid arthritis

    T-regulatory cells in systemic lupus erythematosus and rheumatoid arthritis by A V Torgashina, S Y Biykovskaya, S K Soloviev, E L Nasonov

    Published 2009-06-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Position on the use of anifrolumab in patients with systemic lupus erythematosus with insufficient efficacy of standard therapy in real-life clinical practice. Comments from Russian experts

    Position on the use of anifrolumab in patients with systemic lupus erythematosus with insufficient efficacy of standard therapy in real-life clinical practice. Comments from Russia... by E. A. Aseeva, S. K. Soloviev, T. M. Reshetnyak, A. M. Lila

    Published 2024-06-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus

    Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus by E. A. Aseeva, A. M. Lila, S. K. Soloviev, S. I. Glukhova

    Published 2022-12-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    ATTEMPT OF OVERCOMING SECONDARY INEFFECTIVENESS OF INFLIXIMAB IN A PATIENT WITH ANKYLOSING SPONDYLITIS USING PLASMAPHERESIS (A CASE REPORT)

    ATTEMPT OF OVERCOMING SECONDARY INEFFECTIVENESS OF INFLIXIMAB IN A PATIENT WITH ANKYLOSING SPONDYLITIS USING PLASMAPHERESIS (A CASE REPORT) by Oksana Alekseyevna Rumyantseva, A G Bochkova, S K Soloviev, Sh F Erdes

    Published 2014-02-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Rhupus – a combination of systemic lupus erythematosus and rheumatoid arthritis as a separate disease phenotype (a clinical case)

    Rhupus – a combination of systemic lupus erythematosus and rheumatoid arthritis as a separate disease phenotype (a clinical case) by N. Yu. Nikishina, E. A. Aseeva, A. A. Mesnyankina, S. K. Soloviev

    Published 2023-04-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Characteristics of systemic lupus erythematosus in patients of Asian ethnicity

    Characteristics of systemic lupus erythematosus in patients of Asian ethnicity by G. M. Koilubaeva, E. A. Aseeva, S. K. Soloviev, A. M. Lila

    Published 2025-02-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    2024 ACR guidelines on screening, treatment, and management of patients with lupus nephritis

    2024 ACR guidelines on screening, treatment, and management of patients with lupus nephritis by E. A. Aseeva, S. K. Soloviev, E. A. Pletnev, A. V. Dacina

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Management of patients with systemic lupus erythematosus in real clinical practice

    Management of patients with systemic lupus erythematosus in real clinical practice by E. A. Aseeva, S. K. Soloviev, T. V. Popkova, N. Yu. Nikishina, A. A. Mesnyankina

    Published 2019-05-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Clinical and immunological phenotypes of systemic lupus erythematosus, identified based on cluster analysis of data from 400 patients from V.A. Nasonova Research Institute of Rheumatology

    Clinical and immunological phenotypes of systemic lupus erythematosus, identified based on cluster analysis of data from 400 patients from V.A. Nasonova Research Institute of Rheum... by E. A. Aseeva, A. M. Lila, S. K. Soloviev, E. L. Nasonov, S. I. Glukhova

    Published 2022-10-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Problems of low activity and remission in systemic lupus erythematosus

    Problems of low activity and remission in systemic lupus erythematosus by S. K. Soloviev, E. A. Aseeva, E. G. Zotkin, S. Yu. Kireeva, E. L. Nasonov

    Published 2019-05-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Treatment of patients with systemic lupus erythematosus without glucocorticoids – myth or reality?

    Treatment of patients with systemic lupus erythematosus without glucocorticoids – myth or reality? by S. K. Soloviev, A. A. Mesnyankina, N. Yu. Nikishina, E. A. Aseeva, A. M. Lila

    Published 2022-02-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

    EXPERIENCE WITH BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS by E. A. Aseeva, S. K. Soloviev, A. A. Mesnyankina, M. E. Tsanyan, E. L. Nasonov

    Published 2015-09-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus

    Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus by N. Yu. Nikishina, E. A. Aseeva, S. K. Soloviev, A. M. Lila, A. V. Datcina, E. T. Pletnev

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity

    Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity by E. L. Nasonov, T. V. Beketova, T. M. Reshetnyak, A. M. Lila, L. P. Ananieva, T. A. Lisitsyna, S. K. Soloviev

    Published 2020-09-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: